CervoMed Inc.
CRVO | NASDAQ
$2.54
+$0.13 (+5.39%)
Sep 22, 2026, 3:51 PM ET · Market open
Market Data
Market Cap $22.31M
Enterprise Value $-2.62M
Beta -4.31
Average Volume 5.63M
Shares Outstanding (Diluted) 10.24M
Shares Change YoY 14.46%
Institutional Ownership 19.11%
Exchange NASDAQ
ISIN US15713L1098
Price Performance
Price Change 1M -9.1%
Price Change 3M -35.2%
Price Change 6M -40.4%
Price Change YTD -69.1%
Price Change 1Y -70.5%
Price Change 3Y -44.5%
Price Change 5Y -93.6%
1M CAGR (ann.) -16.0%
1Y CAGR (ann.) -70.3%
5Y CAGR (ann.) -43.1%
All-Time CAGR -58.3%
Valuation
PE Ratio -0.75
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.02
PS Ratio 69.17
Forward PS 22.30
PB Ratio 0.97
P/FCF Ratio -0.80
P/Adj. FCF Ratio -0.77
P/OCF Ratio -0.88
EV/Sales -8.14
EV/EBIT 0.11
EV/EBITDA 0.09
EV/FCF 0.09
Earnings Yield -133.2%
FCF Yield -125.4%
Adj. FCF Yield -129.9%
Financial Health
Net Cash $24.94M
Total Debt $0
Cash & Short-Term Investments $24.94M
Total Assets $25.99M
Current Ratio 8.57
Quick Ratio 8.57
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -3.58
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -9661.4%
EBITDA Margin -9408.8%
Net Profit Margin -9408.8%
FCF Margin -8673.4%
Adj. FCF Margin -8984.4%
SBC / Revenue 311.0%
SBC Impact (per share) -3.6%
Returns
Return on Assets -116.8%
Return on Equity -156.0%
Return on Invested Capital -135.7%
Return on Capital Employed -135.7%
Return on Tangible Assets -116.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y 54.5%
EPS CAGR 3Y -27.9%
EPS CAGR 5Y 52.0%
EPS CAGR 10Y 51.6%
FCF CAGR 3Y -67.2%
FCF CAGR 5Y -35.8%
FCF CAGR 10Y -8.3%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 26.6%
Revenue Growth Next 3Y 175.4%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.61
EPS Growth Est (next Q) -27.4%
Revenue Est (next Q) $50K
Revenue Growth Est (next Q) -84.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside 190.5%
Cash Flow
Operating Cash Flow $-27.98M
Free Cash Flow $-27.98M
Adj. Free Cash Flow $-28.98M
FCF Per Share -$2.73
OCF Per Share -$2.73
OCF/S Ratio -8673.4%
Income Statement
Revenue $322.57K
Gross Profit $322.57K
Operating Income $-31.16M
EBITDA $-30.46M
Net Income $-30.35M
EPS (Diluted) -$3.21
Revenue / Employee $21.5K
Profit / Employee $-2.02M
Employees 15
Add to Watchlist
Select watchlists to add or remove CRVO